Biliary Stenting In The Management Of Difficult Common Bile Duct Stones: A Single Tertiary Center Experience

Aims If common bile duct (CBD) stones (choledocholithiasis) are left untreated, they may cause increases in morbidity and mortality due to several conditions.

In this study, using transient biliary stenting following the failure of an initial endoscopic retrograde cholangiopancreatography (ERCP) session, we aimed to show the effects of making the CBD stones smaller and easier to remove in the following session.

Methods In 126 of 900 (14 %) patients with CBD stones, who underwent balloon screening and/or basket lithotripsy following ERCP and CBD cannulation, it was not possible to remove the stones in the first session. They were further followed and tested following transient biliary stenting.

Results A biliary stent was placed in 103 of 126 patients. While the plastic biliary stent was placed in patients, the mean stone size after the 1st ERCP was 20 mm and the bile duct size was 18 mm. At the time of the 2nd ERCP conducted approximately 83.9 days later, the mean stone size was found to be 14 mm and the bile duct size was 13 mm. With recurrent ERCPs, the CBD stone was successfully removed in 98 patients but could not be removed in 5 patients. Among the 98 successful cases, 59 removals were successful in the 2nd ERCP session, 25 were successful in the 3rd session, 9 were successful in the 4th session, 4 was successful in the 5th session and 1 was successful in the 6th.

Conclusions For CBD stones that cannot be removed by standard methods, temporary plastic stenting may an alternative method.It increases the chance of success in the next session of ERCP.

Citation Amalou K, Belghanem F, Bousseloub A. eP324BILIARY STENTING IN THE MANAGEMENT OF DIFFICULT COMMON BILE DUCT STONES: A SINGLE TERTIARY CENTER EXPERIENCE. Endoscopy 2021; 53: S203.

Publication History

Article published online:
19 March 2021